Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2025(Status and Outlook)
Report Overview
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
This report provides a deep insight into the global Recombinant Human Thrombin for Surgical Hemostasis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Human Thrombin for Surgical Hemostasis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Human Thrombin for Surgical Hemostasis market in any manner.
Global Recombinant Human Thrombin for Surgical Hemostasis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS
Market Segmentation (by Type)
Based Bovine
Based Human
Others
Market Segmentation (by Application)
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant Human Thrombin for Surgical Hemostasis Market
- Overview of the regional outlook of the Recombinant Human Thrombin for Surgical Hemostasis Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Thrombin for Surgical Hemostasis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant Human Thrombin for Surgical Hemostasis
1.2 Key Market Segments
1.2.1 Recombinant Human Thrombin for Surgical Hemostasis Segment by Type
1.2.2 Recombinant Human Thrombin for Surgical Hemostasis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Product Life Cycle
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Human Thrombin for Surgical Hemostasis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Sites, Area Served, Product Type
3.8 Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation and Trends
3.8.1 Recombinant Human Thrombin for Surgical Hemostasis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant Human Thrombin for Surgical Hemostasis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant Human Thrombin for Surgical Hemostasis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Recombinant Human Thrombin for Surgical Hemostasis Market
5.7 ESG Ratings of Leading Companies
6 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Type (2020-2025)
6.4 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Type (2020-2025)
7 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Sales by Application (2020-2025)
7.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
8 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SALES BY REGION
8.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region
8.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region
8.3 North America
8.3.1 North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.3.2 North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.4.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.5.2 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.6.2 South America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.7.2 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET PRODUCTION BY REGION
9.1 Global Production of Recombinant Human Thrombin for Surgical Hemostasis by Region(2020-2025)
9.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Human Thrombin for Surgical Hemostasis Production
9.4.1 North America Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.4.2 North America Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Production
9.5.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Human Thrombin for Surgical Hemostasis Production (2020-2025)
9.6.1 Japan Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Human Thrombin for Surgical Hemostasis Production (2020-2025)
9.7.1 China Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.7.2 China Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Takeda
10.1.1 Takeda Basic Information
10.1.2 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 CSL
10.3.1 CSL Basic Information
10.3.2 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.3.4 CSL Business Overview
10.3.5 CSL SWOT Analysis
10.3.6 CSL Recent Developments
10.4 Grifols
10.4.1 Grifols Basic Information
10.4.2 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.4.4 Grifols Business Overview
10.4.5 Grifols Recent Developments
10.5 GE Healthcare
10.5.1 GE Healthcare Basic Information
10.5.2 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.5.4 GE Healthcare Business Overview
10.5.5 GE Healthcare Recent Developments
10.6 Hualan Biological
10.6.1 Hualan Biological Basic Information
10.6.2 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.6.4 Hualan Biological Business Overview
10.6.5 Hualan Biological Recent Developments
10.7 Haematologic Technologies
10.7.1 Haematologic Technologies Basic Information
10.7.2 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.7.4 Haematologic Technologies Business Overview
10.7.5 Haematologic Technologies Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Octapharma
10.9.1 Octapharma Basic Information
10.9.2 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.9.4 Octapharma Business Overview
10.9.5 Octapharma Recent Developments
10.10 Omrix Biopharmaceuticals
10.10.1 Omrix Biopharmaceuticals Basic Information
10.10.2 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.10.4 Omrix Biopharmaceuticals Business Overview
10.10.5 Omrix Biopharmaceuticals Recent Developments
10.11 Shanghai RAAS
10.11.1 Shanghai RAAS Basic Information
10.11.2 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.11.4 Shanghai RAAS Business Overview
10.11.5 Shanghai RAAS Recent Developments
11 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET FORECAST BY REGION
11.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast
11.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region
11.2.4 South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant Human Thrombin for Surgical Hemostasis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Recombinant Human Thrombin for Surgical Hemostasis by Type (2026-2033)
12.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Recombinant Human Thrombin for Surgical Hemostasis by Type (2026-2033)
12.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Application (2026-2033)
12.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) Forecast by Application
12.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Thrombin for Surgical Hemostasis Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin for Surgical Hemostasis as of 2024)
Table 10. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Sites and Area Served
Table 12. Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Product Type
Table 13. Global Recombinant Human Thrombin for Surgical Hemostasis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (K Units)
Table 25. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Type (M USD)
Table 26. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2020-2025)
Table 27. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2020-2025)
Table 28. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) by Type (2020-2025)
Table 29. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Share by Type (2020-2025)
Table 30. Global Recombinant Human Thrombin for Surgical Hemostasis Price (USD/Unit) by Type (2020-2025)
Table 31. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application
Table 32. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Application
Table 33. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2020-2025) & (K Units)
Table 34. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2020-2025)
Table 35. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Application (2020-2025) & (M USD)
Table 36. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application (2020-2025)
Table 37. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
Table 38. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 39. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2020-2025)
Table 40. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 41. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region (2020-2025)
Table 42. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 43. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 45. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 48. South America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 49. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 52. Global Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) by Region(2020-2025)
Table 53. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2020-2025)
Table 55. Global Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Takeda Basic Information
Table 61. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 62. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Takeda Business Overview
Table 64. Takeda SWOT Analysis
Table 65. Takeda Recent Developments
Table 66. Bayer Basic Information
Table 67. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 68. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Bayer Business Overview
Table 70. Bayer SWOT Analysis
Table 71. Bayer Recent Developments
Table 72. CSL Basic Information
Table 73. CSL Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 74. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. CSL Business Overview
Table 76. CSL SWOT Analysis
Table 77. CSL Recent Developments
Table 78. Grifols Basic Information
Table 79. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 80. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Grifols Business Overview
Table 82. Grifols Recent Developments
Table 83. GE Healthcare Basic Information
Table 84. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 85. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Recent Developments
Table 88. Hualan Biological Basic Information
Table 89. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 90. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Hualan Biological Business Overview
Table 92. Hualan Biological Recent Developments
Table 93. Haematologic Technologies Basic Information
Table 94. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 95. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Haematologic Technologies Business Overview
Table 97. Haematologic Technologies Recent Developments
Table 98. Pfizer Basic Information
Table 99. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 100. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Business Overview
Table 102. Pfizer Recent Developments
Table 103. Octapharma Basic Information
Table 104. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 105. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Octapharma Business Overview
Table 107. Octapharma Recent Developments
Table 108. Omrix Biopharmaceuticals Basic Information
Table 109. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 110. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Omrix Biopharmaceuticals Business Overview
Table 112. Omrix Biopharmaceuticals Recent Developments
Table 113. Shanghai RAAS Basic Information
Table 114. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 115. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Shanghai RAAS Business Overview
Table 117. Shanghai RAAS Recent Developments
Table 118. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Recombinant Human Thrombin for Surgical Hemostasis Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Recombinant Human Thrombin for Surgical Hemostasis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD), 2024-2033
Figure 5. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) (2020-2033)
Figure 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Human Thrombin for Surgical Hemostasis Product Life Cycle
Figure 13. Recombinant Human Thrombin for Surgical Hemostasis Sales Share by Manufacturers in 2024
Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers in 2024
Figure 15. Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Thrombin for Surgical Hemostasis Revenue in 2024
Figure 18. Industry Chain Map of Recombinant Human Thrombin for Surgical Hemostasis
Figure 19. Global Recombinant Human Thrombin for Surgical Hemostasis Market PEST Analysis
Figure 20. Global Recombinant Human Thrombin for Surgical Hemostasis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Type
Figure 27. Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type in 2024
Figure 29. Market Size Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2020-2025)
Figure 30. Market Size Share of Recombinant Human Thrombin for Surgical Hemostasis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application
Figure 33. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application in 2024
Figure 35. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application (2020-2025)
Figure 36. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application in 2024
Figure 37. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region (2020-2025)
Figure 40. North America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 43. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 45. U.S. Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Human Thrombin for Surgical Hemostasis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Human Thrombin for Surgical Hemostasis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 55. Germany Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region in 2024
Figure 68. China Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 79. South America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 80. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 82. Brazil Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Human Thrombin for Surgical Hemostasis Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share Forecast by Type (2026-2033)
Figure 111. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Application (2026-2033)
Figure 112. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share Forecast by Application (2026-2033)
1.1 Market Definition and Statistical Scope of Recombinant Human Thrombin for Surgical Hemostasis
1.2 Key Market Segments
1.2.1 Recombinant Human Thrombin for Surgical Hemostasis Segment by Type
1.2.2 Recombinant Human Thrombin for Surgical Hemostasis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Product Life Cycle
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Human Thrombin for Surgical Hemostasis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Sites, Area Served, Product Type
3.8 Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation and Trends
3.8.1 Recombinant Human Thrombin for Surgical Hemostasis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant Human Thrombin for Surgical Hemostasis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant Human Thrombin for Surgical Hemostasis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Recombinant Human Thrombin for Surgical Hemostasis Market
5.7 ESG Ratings of Leading Companies
6 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Type (2020-2025)
6.4 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Type (2020-2025)
7 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Sales by Application (2020-2025)
7.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
8 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET SALES BY REGION
8.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region
8.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region
8.3 North America
8.3.1 North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.3.2 North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.4.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.5.2 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
8.6.2 South America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
8.7.2 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET PRODUCTION BY REGION
9.1 Global Production of Recombinant Human Thrombin for Surgical Hemostasis by Region(2020-2025)
9.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Human Thrombin for Surgical Hemostasis Production
9.4.1 North America Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.4.2 North America Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Production
9.5.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Human Thrombin for Surgical Hemostasis Production (2020-2025)
9.6.1 Japan Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Human Thrombin for Surgical Hemostasis Production (2020-2025)
9.7.1 China Recombinant Human Thrombin for Surgical Hemostasis Production Growth Rate (2020-2025)
9.7.2 China Recombinant Human Thrombin for Surgical Hemostasis Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Takeda
10.1.1 Takeda Basic Information
10.1.2 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 Bayer
10.2.1 Bayer Basic Information
10.2.2 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 CSL
10.3.1 CSL Basic Information
10.3.2 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.3.4 CSL Business Overview
10.3.5 CSL SWOT Analysis
10.3.6 CSL Recent Developments
10.4 Grifols
10.4.1 Grifols Basic Information
10.4.2 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.4.4 Grifols Business Overview
10.4.5 Grifols Recent Developments
10.5 GE Healthcare
10.5.1 GE Healthcare Basic Information
10.5.2 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.5.4 GE Healthcare Business Overview
10.5.5 GE Healthcare Recent Developments
10.6 Hualan Biological
10.6.1 Hualan Biological Basic Information
10.6.2 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.6.4 Hualan Biological Business Overview
10.6.5 Hualan Biological Recent Developments
10.7 Haematologic Technologies
10.7.1 Haematologic Technologies Basic Information
10.7.2 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.7.4 Haematologic Technologies Business Overview
10.7.5 Haematologic Technologies Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Octapharma
10.9.1 Octapharma Basic Information
10.9.2 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.9.4 Octapharma Business Overview
10.9.5 Octapharma Recent Developments
10.10 Omrix Biopharmaceuticals
10.10.1 Omrix Biopharmaceuticals Basic Information
10.10.2 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.10.4 Omrix Biopharmaceuticals Business Overview
10.10.5 Omrix Biopharmaceuticals Recent Developments
10.11 Shanghai RAAS
10.11.1 Shanghai RAAS Basic Information
10.11.2 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Overview
10.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Market Performance
10.11.4 Shanghai RAAS Business Overview
10.11.5 Shanghai RAAS Recent Developments
11 RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS MARKET FORECAST BY REGION
11.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast
11.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region
11.2.4 South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant Human Thrombin for Surgical Hemostasis by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Recombinant Human Thrombin for Surgical Hemostasis by Type (2026-2033)
12.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Recombinant Human Thrombin for Surgical Hemostasis by Type (2026-2033)
12.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Forecast by Application (2026-2033)
12.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) Forecast by Application
12.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Thrombin for Surgical Hemostasis Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin for Surgical Hemostasis as of 2024)
Table 10. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Sites and Area Served
Table 12. Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Product Type
Table 13. Global Recombinant Human Thrombin for Surgical Hemostasis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (K Units)
Table 25. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Type (M USD)
Table 26. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2020-2025)
Table 27. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2020-2025)
Table 28. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) by Type (2020-2025)
Table 29. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Share by Type (2020-2025)
Table 30. Global Recombinant Human Thrombin for Surgical Hemostasis Price (USD/Unit) by Type (2020-2025)
Table 31. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application
Table 32. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Application
Table 33. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2020-2025) & (K Units)
Table 34. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2020-2025)
Table 35. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Application (2020-2025) & (M USD)
Table 36. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application (2020-2025)
Table 37. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
Table 38. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 39. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2020-2025)
Table 40. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 41. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region (2020-2025)
Table 42. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 43. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 45. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 48. South America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2020-2025) & (K Units)
Table 49. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (2020-2025) & (M USD)
Table 52. Global Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) by Region(2020-2025)
Table 53. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2020-2025)
Table 55. Global Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Recombinant Human Thrombin for Surgical Hemostasis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Takeda Basic Information
Table 61. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 62. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Takeda Business Overview
Table 64. Takeda SWOT Analysis
Table 65. Takeda Recent Developments
Table 66. Bayer Basic Information
Table 67. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 68. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Bayer Business Overview
Table 70. Bayer SWOT Analysis
Table 71. Bayer Recent Developments
Table 72. CSL Basic Information
Table 73. CSL Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 74. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. CSL Business Overview
Table 76. CSL SWOT Analysis
Table 77. CSL Recent Developments
Table 78. Grifols Basic Information
Table 79. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 80. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Grifols Business Overview
Table 82. Grifols Recent Developments
Table 83. GE Healthcare Basic Information
Table 84. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 85. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. GE Healthcare Business Overview
Table 87. GE Healthcare Recent Developments
Table 88. Hualan Biological Basic Information
Table 89. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 90. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Hualan Biological Business Overview
Table 92. Hualan Biological Recent Developments
Table 93. Haematologic Technologies Basic Information
Table 94. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 95. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Haematologic Technologies Business Overview
Table 97. Haematologic Technologies Recent Developments
Table 98. Pfizer Basic Information
Table 99. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 100. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Business Overview
Table 102. Pfizer Recent Developments
Table 103. Octapharma Basic Information
Table 104. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 105. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Octapharma Business Overview
Table 107. Octapharma Recent Developments
Table 108. Omrix Biopharmaceuticals Basic Information
Table 109. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 110. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Omrix Biopharmaceuticals Business Overview
Table 112. Omrix Biopharmaceuticals Recent Developments
Table 113. Shanghai RAAS Basic Information
Table 114. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Overview
Table 115. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Shanghai RAAS Business Overview
Table 117. Shanghai RAAS Recent Developments
Table 118. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Recombinant Human Thrombin for Surgical Hemostasis Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Recombinant Human Thrombin for Surgical Hemostasis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD), 2024-2033
Figure 5. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) (2020-2033)
Figure 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Human Thrombin for Surgical Hemostasis Product Life Cycle
Figure 13. Recombinant Human Thrombin for Surgical Hemostasis Sales Share by Manufacturers in 2024
Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers in 2024
Figure 15. Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Thrombin for Surgical Hemostasis Revenue in 2024
Figure 18. Industry Chain Map of Recombinant Human Thrombin for Surgical Hemostasis
Figure 19. Global Recombinant Human Thrombin for Surgical Hemostasis Market PEST Analysis
Figure 20. Global Recombinant Human Thrombin for Surgical Hemostasis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Type
Figure 27. Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type in 2024
Figure 29. Market Size Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2020-2025)
Figure 30. Market Size Share of Recombinant Human Thrombin for Surgical Hemostasis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application
Figure 33. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application in 2024
Figure 35. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application (2020-2025)
Figure 36. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application in 2024
Figure 37. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region (2020-2025)
Figure 40. North America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 43. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 45. U.S. Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Human Thrombin for Surgical Hemostasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Human Thrombin for Surgical Hemostasis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Human Thrombin for Surgical Hemostasis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 55. Germany Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region in 2024
Figure 68. China Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 79. South America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2024
Figure 80. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Country in 2024
Figure 82. Brazil Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Human Thrombin for Surgical Hemostasis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Human Thrombin for Surgical Hemostasis Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Recombinant Human Thrombin for Surgical Hemostasis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share Forecast by Type (2026-2033)
Figure 111. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Application (2026-2033)
Figure 112. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share Forecast by Application (2026-2033)
